BTG Stock Overview
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Beroni Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.99 |
| 52 Week High | AU$0.99 |
| 52 Week Low | AU$0.99 |
| Beta | 0.14 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 160.53% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BTG | AU Biotechs | AU Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 0.7% |
| 1Y | n/a | -7.4% | 6.3% |
Return vs Industry: Insufficient data to determine how BTG performed against the Australian Biotechs industry.
Return vs Market: Insufficient data to determine how BTG performed against the Australian Market.
Price Volatility
| BTG volatility | |
|---|---|
| BTG Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: BTG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BTG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Jacky Zhang | www.beronigroup.com |
Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, and health care products and supplements in China, Australia, the United States, and Japan. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic products, and Viral Diagnostic Kits segments. The company’s products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system.
Beroni Group Limited Fundamentals Summary
| BTG fundamental statistics | |
|---|---|
| Market cap | AU$75.87m |
| Earnings (TTM) | -AU$4.45m |
| Revenue (TTM) | AU$1.91m |
39.8x
P/S Ratio-17.0x
P/E RatioIs BTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BTG income statement (TTM) | |
|---|---|
| Revenue | AU$1.91m |
| Cost of Revenue | AU$424.61k |
| Gross Profit | AU$1.48m |
| Other Expenses | AU$5.93m |
| Earnings | -AU$4.45m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 77.73% |
| Net Profit Margin | -233.47% |
| Debt/Equity Ratio | 7.9% |
How did BTG perform over the long term?
See historical performance and comparison